Follow
Biomarker in leukemia
Biomarkers are biological molecules which indicate a normal or abnormal physiological process or a disease. Biomarkers in leukemia can be used to classify the subtype of disease or determine the best course of treatment for an individual patient. Common leukemia biomarkers are called cluster of differentiation (CD) markers which can be evaluated on the surface of leukocytes.
What's Popular in Biomarker in leukemia
JUL 22 2021 | 5:00 PM
C.E. CREDITS
Though tumor targeting using chimeric receptors (CAR) engineered to bind tumor-associated surface proteins such as CD19 in B cells have demonstrated remarkable efficacy in cancer, this thera...
NOV 20 2020 | 10:00 AM
Date: November 20, 2020 Time: 10:00am (PST), 1:00pm (EST) This webinar will provide an overview of the Bio-Techne technologies being used by Biopharma for the development of biomarkers and c...
OCT 7 2020 | 10:30 AM
Tumor phenotypes are dictated not only by the neoplastic cell component, but also by the tumor microenvironment (TME), which is inherently immuno-suppressive, is equipped to hamper effector...
SEP 23 2020 | 6:30 AM
Single-cell mass cytometry identifies mechanisms of resistance to immunotherapy in AML 6:30–7:00 am PDT Presented By: Shelley Herbrich, PhD Understanding CD19 negative relapse followin...
